Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...

"The latest findings highlight the potential of tissue patches derived from stem cells to treat heart failure, which remains one of the leading causes of death worldwide". Muscle patches made with ...

Jan. 24, 2025 — A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at ...

Every new year brings a bunch of new laws that kick in either right away or sometime during the year. Let's talk about a few of them. In this edition of the "Sheriff's Corner", I cover new laws for ...

One common, and often successful, way to keep a safety net hospital afloat is by having it in a system with other hospitals ...

The clinical chemistry test is intended to help diagnose heart failure using the N-terminal pro b-type natriuretic peptide biomarker.

Houston’s medical powerhouses are among those waiting to see how federal changes will shake out, and for good reason — some ...

Morgans analyst Scott Power says there's been a rotation back into small healthcare stocks as EBR Systems records a massive ...

President Donald Trump’s pick to lead the Department of Health and Human Services, Robert F. Kennedy Junior, fielded tough ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Grafting patches of lab-grown muscle to the surface of the heart could offer a lifeline for people waiting for a transplant.

Muscle patches generated from stem cells helped ease heart problems in monkeys and a human patient, in a potential advance ...